Vanguard Portfolio Management’s Armata Pharmaceuticals ARMP Stock Holding History

Vanguard Portfolio Management’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$527K	Buy	+81,354	New	+$746K	﹤0.01%	3054

Other funds holding ARMP

MAM

Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Vanguard Portfolio Management's ARMP Position: Q2 2026 in Review

Vanguard Portfolio Management opened a new position in Armata Pharmaceuticals (ARMP) in Q2 2026: 81,354 shares worth $527K. The stake represents ﹤0.01% of the portfolio and ranks #3054 among its holdings.

53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

Vanguard Portfolio Management held 81,354 shares of Armata Pharmaceuticals worth $527K as of Q2 2026.
Armata Pharmaceuticals was a new Vanguard Portfolio Management position in Q2 2026.
Armata Pharmaceuticals made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #3054 holding.
53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.